Crosstalk between the FGFR2 and TP53 genes in breast cancer: Data from an association study and epistatic interaction analysis

DNA and Cell Biology

Volumn 31, Issue 3, 2012, Pages 305-315

  Cherdyntseva, Nadezhda V ^a   Denisov, Evgeny V ^a   Litviakov, Nicolay V ^a   Maksimov, Vladimir N ^b   Malinovskaya, Elena A ^a   Babyshkina, Natalia N ^a   Slonimskaya, Elena M ^a,c   Voevoda, Mikhail I ^b   Choinzonov, Evgeny L ^a,c  

^a CANCER RESEARCH INSTITUTE   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^c SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; PROTEIN P53; FGFR2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84858146216     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1351     Document Type: Article

References (55)

1. Adnane, J., Gaudray, P., Dionne, C.A., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., and Theillet, C. (1991). BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6, 659-663. (Pubitemid 21924133)
2. Ara, S., Lee, P.S., Hansen, M.F., and Saya, H. (1990). Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18, 4961. (Pubitemid 20280142)
3. Benz, C.C. (2008). Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 66, 65-74. (Pubitemid 351324129)
4. Brown, J.D. (2004). Yates correction factor. Shiken: JALT Testing & Evaluation SIG Newsletter 8, 22-27.
5. Cherdyntseva, N., Gervas, P., Litvyakov, N., Stakcheeva, M., Ponomaryeva, A., Dobrodeev, A., Denisov, E., Belyavskaya, V., and Choinzonov, E. (2010). Age-related function of tumor suppressor gene TP53: contribution to cancer risk and progression. Exp Oncol 32, 205-208.
6. Chung, W.H., Dao, R.L., Chen, L.K., and Hung, S.I. (2010). The role of genetic variants in human longevity. Ageing Res Rev 9(Suppl 1), S67-78.
7. Conrad, D.F., Jakobsson, M., Coop, G., Wen, X., Wall, J.D., Rosenberg, N.A., and Pritchard, J.K. (2006). A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat Genet 38, 1251-1260. (Pubitemid 44646287)
8. Cordell, H.J. (2009). Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 10, 392-404.
9. Denisov, E.V., Cherdyntseva, N.V., Litvyakov, N.V., Slonimskaya, E.M., Malinovskaya, E.A., Voevoda, M.I., Belyavskaya, V.A., and Stegniy, V.N. (2009). TP53 mutations and Arg72Pro polymorphism in breast cancers. Cancer Genet Cytogenet 192, 93-95.
10. Denisov, E.V., Sukhanovskaya, T.V., Dultseva, T.S., Malinovskaya, E.A., Litviakov, N.V., Slonimskaya, E.M., Choinzonov, E.L., and Cherdyntseva, N.V. Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation and mutations. Genet Test Mol Biomarkers 2011 DOI: 10.1089/gtmb.2011.0038.
11. Donehower, L. (2006). p53, longevity assurance and longevity suppression. Drug Discov Today Dis Mech 3, 33-39. (Pubitemid 44044597)
12. Dumont, P., Leu, J.I., Della Pietra, A.C., 3rd, George, D.L., and Murphy, M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33, 357-365. (Pubitemid 36278852)
13. Easton, D.F., Pooley, K.A., Dunning, A.M., Pharoah, P.D., Thompson, D., Ballinger, D.G., Struewing, J.P., Morrison, J., Field, H., Luben, R., Wareham, N., Ahmed, S., Healey, C.S., Bowman, R., Meyer, K.B., Haiman, C.A., Kolonel, L.K., Henderson, B.E., Le Marchand, L., Brennan, P., Sangrajrang, S., Gaborieau, V., Odefrey, F., Shen, C.Y., Wu, P.E., Wang, H.C., Eccles, D., Evans, D.G., Peto, J., Fletcher, O., Johnson, N., Seal, S., Stratton, M.R., Rahman, N., Chenevix-Trench, G., Bojesen, S.E., Nordestgaard, B.G., Axelsson, C.K., Garcia-Closas, M., Brinton, L., Chanock, S., Lissowska, J., Peplonska, B., Nevanlinna, H., Fagerholm, R., Eerola, H., Kang, D., Yoo, K.Y., Noh, D.Y., Ahn, S.H., Hunter, D.J., Hankinson, S.E., Cox, D.G., Hall, P., Wedren, S., Liu, J., Low, Y.L., Bogdanova, N., Schurmann, P., Dork, T., Tollenaar, R.A., Jacobi, C.E., Devilee, P., Klijn, J.G., Sigurdson, A.J., Doody, M.M., Alexander, B.H., Zhang, J., Cox, A., Brock, I.W., MacPherson, G., Reed, M.W., Couch, F.J., Goode, E.L., Olson, J.E., Meijers-Heijboer, H., van den Ouweland, A., Uitterlinden, A., Rivadeneira, F., Milne, R.L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Hopper, J.L., McCredie, M., Southey, M., Giles, G.G., Schroen, C., Justenhoven, C., Brauch, H., Hamann, U., Ko, Y.D., Spurdle, A.B., Beesley, J., Chen, X., Mannermaa, A., Kosma, V.M., Kataja, V., Hartikainen, J., Day, N.E., Cox, D.R., and Ponder, B.A. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093. (Pubitemid 47014426)
14. Frank, A.K., Leu, J.I., Zhou, Y., Devarajan, K., Nedelko, T., Klein-Szanto, A., Hollstein, M., and Murphy, M.E. (2011). The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol 31, 1201-1213.
15. Garner, I. (2000). Isolation of high-molecular-weight DNA from animal cells. In The Nucleic Acid Protocols Handbook. R. Rapley, ed. (Humana Press Inc.), Otowa, NJ, USA pp. 3-7.
16. Givol, D., and Yayon, A. (1992). Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6, 3362-3369. (Pubitemid 23007101)
17. GLOBOCAN. (2008). Breast cancer incidence and mortality worldwide in 2008. Available at: http://globocan.iarc.fr/factsheets/cancers/breast.asp. Accessed on May 20, 2011
18. Grady, B.J., Torstenson, E.S., and Ritchie, M.D. (2011). The effects of linkage disequilibrium in large scale SNP datasets for MDR. BioData Min 4, 11.
19. Greene, C.S., Himmelstein, D.S., Nelson, H.H., Kelsey, K.T., Williams, S.M., Andrew, A.S., Karagas, M.R., and Moore, J.H. (2010). Enabling personal genomics with an explicit test of epistasis. Presented at the Proceedings of the Pacific Symposium BIOCOMPUTING 2010, Kamuela, January 4-8, pp. 327-336.
20. Hosokawa, K., Aharoni, D., Dantes, A., Shaulian, E., Schere-Levy, C., Atzmon, R., Kotsuji, F., Oren, M., Vlodavsky, I., and Amsterdam, A. (1998). Modulation of Mdm2 expression and p53-induced apoptosis in immortalized human ovarian granulosa cells. Endocrinology 139, 4688-4700. (Pubitemid 28487788)
21. Hua, X., Zhang, H., Yang, Y., and Kuk, A.Y. (2010). Testing multiple gene interactions by the ordered combinatorial partitioning method in case-control studies. Bioinformatics 26, 1871-1878.
22. Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., Wang, J., Yu, K., Chatterjee, N., Orr, N., Willett, W.C., Colditz, G.A., Ziegler, R.G., Berg, C.D., Buys, S.S., McCarty, C.A., Feigelson, H.S., Calle, E.E., Thun, M.J., Hayes, R.B., Tucker, M., Gerhard, D.S., Fraumeni, J.F., Jr., Hoover, R.N., Thomas, G., and Chanock, S.J. (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39, 870-874. (Pubitemid 47014500)
23. Katoh, M. (2009). FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies. J Invest Dermatol 129, 1861-1867.
24. Kawase, T., Matsuo, K., Suzuki, T., Hiraki, A., Watanabe, M., Iwata, H., Tanaka, H., and Tajima, K. (2009). FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. Int J Cancer 125, 1946-1952.
25. Koziczak, M., Holbro, T., and Hynes, N.E. (2004). Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 23, 3501-3508. (Pubitemid 38658416)
26. Li, J. (2011). Genetic Determinants of Breast Cancer Risk. Doctoral thesis. Karolinska Institutet. Stockholm, Sweden.
27. Li, J., Humphreys, K., Heikkinen, T., Aittomaki, K., Blomqvist, C., Pharoah, P.D., Dunning, A.M., Ahmed, S., Hooning, M.J., Martens, J.W., van den Ouweland, A.M., Alfredsson, L., Palotie, A., Peltonen-Palotie, L., Irwanto, A., Low, H.Q., Teoh, G.H., Thalamuthu, A., Easton, D.F., Nevanlinna, H., Liu, J., Czene, K., and Hall, P. (2010). A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 126, 717-727.
28. Liang, J., Chen, P., Hu, Z., Zhou, X., Chen, L., Li, M., Wang, Y., Tang, J., Wang, H., and Shen, H. (2008). Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29, 2341-2346.
29. Litviakov, N., Denisov, E., Ravil'M, T., Karpov, A., Skobel'skaja, E., Vasil'eva, E., Goncharik, O., Ageeva, A., Mamonova, N., and Mezheritskiy, S. (2010). Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers. Mol Carcinog 49, 521-524.
30. McCarthy, N. (2011). Tumour suppressors: Selective justice. Nat Rev Cancer 11, 4.
31. Menashe, I., Maeder, D., Garcia-Closas, M., Figueroa, J.D., Bhattacharjee, S., Rotunno, M., Kraft, P., Hunter, D.J., Chanock, S.J., Rosenberg, P.S., and Chatterjee, N. (2010). Pathwayanalysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res 70, 4453-4459.
32. Meyer, K.B., Maia, A.T., O'Reilly, M., Teschendorff, A.E., Chin, S.F., Caldas, C., and Ponder, B.A. (2008). Allele-specific upregulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6, e108.
33. Moore, J.H. (2003). The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56, 73-82. (Pubitemid 37465073)
34. Moore, J.H., Gilbert, J.C., Tsai, C.T., Chiang, F.T., Holden, T., Barney, N., and White, B.C. (2006). A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241, 252-261. (Pubitemid 43993963)
35. Motulsky, H. (1995) Intuitive Biostatistics (Oxford University Press, New York).
36. Murakami, M., Nguyen, L.T., Hatanaka, K., Schachterle, W., Chen, P.Y., Zhuang, Z.W., Black, B.L., and Simons, M. (2011). FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest 121, 2668-2678.
37. Ota, S., Zhou, Z.Q., Link, J.M., and Hurlin, P.J. (2009). The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects. Hum Mol Genet 18, 2609-2621.
38. Peng, S., Lu, B., Ruan, W., Zhu, Y., Sheng, H., and Lai, M. (2011). Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 127, 309-324.
39. Perel'muter, V.M., Zav'ialova, M.V., Vtorushin, S.V., Slonimskaia, E.M., Kritskaia, N.G., Garbukov, E., Litviakov, N.V., Stakheeva, M.N., Babyshkina, N.N., Malinovskaia, E.A., Denisov, E.V., Grigor'eva, E.S., Nazarenko, M.S., Sennikov, S.V., Goreva, E.P., Kozlov, V.A., Voevoda, M.I., Maksimov, V.N., Beliavskaia, V.A., and Cherdyntseva, N.V. (2008). Genetic and clinical and pathological characteristics of breast cancer in premenopausal and postmenopausal women. Adv Gerontol (Russian) 21, 643-653.
40. Prentice, R.L., Huang, Y., Hinds, D.A., Peters, U., Pettinger, M., Cox, D.R., Beilharz, E., Chlebowski, R.T., Rossouw, J.E., Caan, B., and Ballinger, D.G. (2009). Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev 18, 3079-3085.
41. Quong, J., Eppenberger-Castori, S., Moore, D., 3rd, Scott, G.K., Birrer, M.J., Kueng, W., Eppenberger, U., and Benz, C.C. (2002). Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res Treat 76, 221-236. (Pubitemid 35335212)
42. Rebbeck, T.R., DeMichele, A., Tran, T.V., Panossian, S., Bunin, G.R., Troxel, A.B., and Strom, B.L. (2009). Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis 30, 269-274.
43. Rosner, B. (2006). Fundamentals of Biostatistics (Thomson Learning, Stamford, CT).
44. Shaulian, E., Resnitzky, D., Shifman, O., Blandino, G., Amsterdam, A., Yayon, A., and Oren, M. (1997). Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 15, 2717-2725. (Pubitemid 27507619)
45. Sjalander, A., Birgander, R., Kivela, A., and Beckman, G. (1995). p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45, 144-149.
46. Sokolenko, A.P., Mitiushkina, N.V., Buslov, K.G., Bit-Sava, E.M., Iyevleva, A.G., Chekmariova, E.V., Kuligina, E., Ulibina, Y.M., Rozanov, M.E., Suspitsin, E.N., Matsko, D.E., Chagunava, O.L., Trofimov, D.Y., Devilee, P., Cornelisse, C., Togo, A.V., Semiglazov, V.F., and Imyanitov, E.N. (2006). High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42, 1380-1384. (Pubitemid 43903155)
47. Tozlu, S., Girault, I., Vacher, S., Vendrell, J., Andrieu, C., Spyratos, F., Cohen, P., Lidereau, R., and Bieche, I. (2006). Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer 13, 1109-1120. (Pubitemid 46212566)
48. Turner, N., and Grose, R. (2010). Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10, 116-129.
49. Turner, S.D., and Bush, W.S. (2011). Multivariate analysis of regulatory snps: empowering personal genomics by considering cis-epistasis and heterogeneity. Presented at the Proceedings of the Pacific Symposium BIOCOMPUTING 2011, Kohala Coast, January 3-7, pp. 276-287.
50. Tyler, A.L., Asselbergs, F.W., Williams, S.M., and Moore, J.H. (2009). Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. Bioessays 31, 220-227.
51. van Heemst, D., Mooijaart, S.P., Beekman, M., Schreuder, J., de Craen, A.J., Brandt, B.W., Slagboom, P.E., and Westendorp, R.G. (2005). Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 40, 11-15. (Pubitemid 40138741)
52. Weston, A., Pan, C.F., Ksieski, H.B., Wallenstein, S., Berkowitz, G.S., Tartter, P.I., Bleiweiss, I.J., Brower, S.T., Senie, R.T., and Wolff, M.S. (1997). p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6, 105-112. (Pubitemid 27069203)
53. Whibley, C., Pharoah, P.D., and Hollstein, M. (2009). p53 polymorphisms: cancer implications. Nat Rev Cancer 9, 95-107.
54. Wu, X., Zhao, H., Amos, C.I., Shete, S., Makan, N., Hong, W.K., Kadlubar, F.F., and Spitz, M.R. (2002). p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94, 681-690. (Pubitemid 34552489)
55. Zhang, J., Qiu, L.X., Wang, Z.H., Leaw, S.J., Wang, B.Y., Wang, J.L., Cao, Z.G., Gao, J.L., and Hu, X.C. (2010). Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124, 419-424.